A 64-year-old man with type 2 diabetes, eGFR 55 mL per minute per 1.73 m2, and prior myocardial infarction is on metformin and maximum-tolerated ACE i...

Question

A 64-year-old man with type 2 diabetes, eGFR 55 mL per minute per 1.73 m2, and prior myocardial infarction is on metformin and maximum-tolerated ACE inhibitor. HbA1c is 7.4 percent. According to Diabetes Canada and CCS recommendations, which additional glucose-lowering agent provides the greatest cardiovascular benefit?

Accepted Answer

SGLT2 inhibitor such as empagliflozin

Answer

Dipeptidyl peptidase-4 inhibitor

Answer

Sulfonylurea

Answer

Thiazolidinedione

Answer

Meglitinide

ca-mccqe1 MCQ (SBA): Type 2 diabetes with cardiovascular disease